# ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder

> **NCT00613067** · NA · COMPLETED · sponsor: **Inje University** · enrollment: 35 (estimated)

## Conditions studied

- Generalized Anxiety Disorder

## Interventions

- **DRUG:** escitalopram

## Key facts

- **NCT ID:** NCT00613067
- **Lead sponsor:** Inje University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2010-04
- **Final completion:** 2010-05
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2010-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00613067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00613067, "ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00613067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*